K Pharma,Inc. (4896.T)

JPY 756.0

(-1.82%)

Operating Expenses Summary of K Pharma,Inc.

  • K Pharma,Inc.'s latest annual operating expenses in 2023 was 543.94 Million JPY , up 53.75% from previous year.
  • K Pharma,Inc.'s latest quarterly operating expenses in 2024 Q2 was 192.7 Million JPY , down -16.5% from previous quarter.
  • K Pharma,Inc. reported a annual operating expenses of 353.77 Million JPY in annual operating expenses 2022, up 61.18% from previous year.
  • K Pharma,Inc. reported a annual operating expenses of 219.49 Million JPY in annual operating expenses 2021, down 0.0% from previous year.
  • K Pharma,Inc. reported a quarterly operating expenses of 230.78 Million JPY for 2024 Q1, up 54.08% from previous quarter.
  • K Pharma,Inc. reported a quarterly operating expenses of 135.27 Million JPY for 2023 Q3, down 0.0% from previous quarter.

Annual Operating Expenses Chart of K Pharma,Inc. (2023 - 2021)

Historical Annual Operating Expenses of K Pharma,Inc. (2023 - 2021)

Year Operating Expenses Operating Expenses Growth
2023 543.94 Million JPY 53.75%
2022 353.77 Million JPY 61.18%
2021 219.49 Million JPY 0.0%

Peer Operating Expenses Comparison of K Pharma,Inc.

Name Operating Expenses Operating Expenses Difference
KOHJIN BIO CO LTD 1.28 Billion JPY 57.653%
PRISM BioLab Co.,LTD 576.81 Million JPY 5.699%
GNI Group Ltd. 9.32 Billion JPY 94.165%
Linical Co., Ltd. 2.7 Billion JPY 79.893%
Trans Genic Inc. 2.15 Billion JPY 74.815%
MEDINET Co., Ltd. 1.49 Billion JPY 63.522%
Soiken Holdings Inc. 3.07 Billion JPY 82.288%
Cytori Cell Research Institute, Inc. 1.85 Billion JPY 70.708%
AnGes, Inc. 8.9 Billion JPY 93.89%
OncoTherapy Science, Inc. 943.08 Million JPY 42.323%
Nxera Pharma Co., Ltd. 19.19 Billion JPY 97.165%
Immuno-Biological Laboratories Co., Ltd. 412.99 Million JPY -31.708%
NanoCarrier Co., Ltd. 975.37 Million JPY 44.232%
Carna Biosciences, Inc. 2.56 Billion JPY 78.815%
CanBas Co., Ltd. 278 Million JPY -95.663%
D. Western Therapeutics Institute, Inc. 1.14 Billion JPY 52.35%
RaQualia Pharma Inc. 1.81 Billion JPY 70.079%
Chiome Bioscience Inc. 1.6 Billion JPY 66.083%
Kidswell Bio Corporation 2.37 Billion JPY 77.088%
PeptiDream Inc. 9.68 Billion JPY 94.385%
Oncolys BioPharma Inc. 1.96 Billion JPY 72.256%
Ribomic Inc. 1.1 Billion JPY 50.805%
SanBio Company Limited 4.53 Billion JPY 88.016%
Healios K.K. 3.48 Billion JPY 84.401%
BrightPath Biotherapeutics Co., Ltd. 1.15 Billion JPY 52.895%
Kubota Pharmaceutical Holdings Co., Ltd. 1.33 Billion JPY 59.239%
Delta-Fly Pharma, Inc. 1.4 Billion JPY 61.243%
StemRIM 2.07 Billion JPY 73.799%
CellSource Co., Ltd. 1.96 Billion JPY 72.297%
FunPep Company Limited 313.82 Million JPY -73.329%
Kringle Pharma, Inc. 958.01 Million JPY 43.222%
Stella Pharma Corporation 963.98 Million JPY 43.574%
TMS Co., Ltd. 943.25 Million JPY 42.333%
Noile-Immune Biotech Inc. 1.08 Billion JPY 50.095%
Cuorips Inc. 598.11 Million JPY 9.058%
Takara Bio Inc. 23.9 Billion JPY 97.725%
ReproCELL Incorporated 1.51 Billion JPY 64.073%
PhoenixBio Co., Ltd. 1.18 Billion JPY 54.059%
StemCell Institute Inc. 1.16 Billion JPY 53.194%
Japan Tissue Engineering Co., Ltd. 1.52 Billion JPY 64.268%
CellSeed Inc. 804.93 Million JPY 32.424%